carnosine has been researched along with Allodynia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiruma, S; Kawabata, A; Kimura, T; Matsuyama, K; Moriyama, M; Murakami-Nakayama, M; Sekiguchi, F; Tsubota, M | 1 |
Egashira, N; Kaname, T; Kawashiri, T; Shiraishi, H; Tsutsumi, K | 1 |
2 other study(ies) available for carnosine and Allodynia
Article | Year |
---|---|
Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Topics: Administration, Ophthalmic; Animals; Anti-Ulcer Agents; Antioxidants; Calcium Channels, T-Type; Carnosine; Cyclophosphamide; Cystitis, Interstitial; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hyperalgesia; Mice, Inbred Strains; Organometallic Compounds; Urinary Bladder; Zinc Compounds | 2015 |
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Carnosine; Cell Line, Tumor; Cell Survival; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neoplasms; Organometallic Compounds; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Tumor Burden; Zinc Compounds | 2016 |